10 Years, Zero Regrets: The Dividend Stocks I Keep Buying

The article highlights AbbVie, Coca-Cola, and PepsiCo as durable dividend names, emphasizing consistent payout growth and shareholder returns. AbbVie reported $15 billion in revenue, up 12.4% year over year, and raised full-year revenue guidance to $67.3 billion with adjusted EPS guidance to $14.08-$14.28; Coca-Cola posted 12% revenue growth to $12.47 billion and PepsiCo delivered 8.5% revenue growth with a 24% jump in operating profit. All three are presented as defensive, income-oriented buys, with yields ranging from 2.69% to 3.61% and long dividend growth streaks.

Analysis

The common denominator here is not “dividend safety” but balance-sheet discipline under slower macro growth. In a world where rates may stay sticky, these are effectively duration-short equity bonds with embedded call options on earnings resilience; the market is rewarding visible cash return over pure top-line growth. That said, the real competitive edge differs: ABBV is a pipeline/transition story with patent risk as a latent overhang, while KO and PEP are margin-compounders whose pricing power and mix shift can keep cash flow ahead of inflation.

Second-order, the strongest beneficiary may be the retailers and distributors that sell these brands rather than the companies themselves: stable household staples demand supports shelf space, trade spend efficiency, and promotional discipline across the sector. On the flip side, higher-yield consumer staples can crowd out lower-quality dividend names, widening the valuation gap between “bond proxies with growth” and “yield traps.” If capital keeps rotating into quality income, weaker balance-sheet consumer names will likely lag even if the broader market stays constructive.

The key risk is not near-term earnings; it is multiple compression if rates back up or if investors decide these names are too crowded. ABBV has the most binary setup over 6–18 months because any slowdown in replacement growth would quickly re-rate the stock despite today’s cash return. KO and PEP have lower fundamental downside but are more exposed to sentiment reversal if defensive sectors de-rate as cyclicals reaccelerate.

The contrarian view is that the trade is already partially owned: these stocks are being bought as substitutes for cash and bonds, so some of the defensive premium may be stretched. The better expression is relative value, not outright chase — own the best cash-return compounder versus the weakest in the same income sleeve, rather than adding broad dividend beta.

Key Decisions for Investors

• Long ABBV on a 3–6 month horizon on pullbacks below recent support; target a re-rating toward the high end of the historical dividend-premium range, but size modestly because the patent-transition risk makes the payoff path uneven.
• Pair trade: long KO / short a lower-quality packaged-food dividend name or broad consumer staples ETF for 3–9 months; thesis is that KO’s mix and pricing power deserve a premium while the sector’s weaker names face margin compression.
• Long PEP vs short XLP as a relative-value expression if rates stay elevated; PEP’s blend of snacks + beverages offers better organic growth support than the basket and should outperform on any defensive rotation.
• Sell cash-secured puts on ABBV or KO into market volatility for 30–60 day premium capture; the downside is cushioned by yield support, and implied vol should overstate realized volatility unless rates spike sharply.
• Avoid adding to the names as a pure duration substitute if the 10Y Treasury keeps grinding higher; in that regime, trim 20–30% of the defensive income book and rotate into shorter-duration cash-flow growers.